HARBIN GLORIA PHARMACEUTICALS Co., LTD (SZSE:002437) agreed to acquire additional 10% stake in Harbin Dandelion Pharmaceuticals Co., Ltd. from Harbin Hanjun Investment Co., Ltd. for CNY 35 million on October 15, 2023. This has been approved in the 9th Meeting of the HARBIN GLORIA PHARMACEUTICALS Co., LTD (SZSE:002437) 6th Directorate held on October 15, 2023, and does not need the Shareholders? Approval.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2.14 CNY | +2.39% | +7.54% | -14.74% |
1st Jan change | Capi. | |
---|---|---|
-14.74% | 655M | |
+20.81% | 43.34B | |
+20.44% | 21.96B | |
+13.30% | 14.09B | |
+12.97% | 13.64B | |
+39.74% | 11.43B | |
-8.59% | 6.86B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+9.64% | 5.22B |
- Stock Market
- Equities
- 002437 Stock
- News Harbin Gloria Pharmaceuticals Co., Ltd
- HARBIN GLORIA PHARMACEUTICALS Co., LTD agreed to acquire additional 10% stake in Harbin Dandelion Pharmaceuticals Co., Ltd. from Harbin Hanjun Investment Co., Ltd. for CNY 35 million.